Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

MMS/MART-1 Immunostaining for Atypical Melanocytes

J Am Acad Dermatol; ePub 2018 Jul 9; Etzkorn, et al

Mohs micrographic surgery (MMS) with MART-1 immunostaining achieves excellent local control of specialty-site atypical intraepidermal melanocytic proliferation (AIMP) and permits definitive removal of subclinical spread prior to reconstruction. This according to a study that sought to ascertain the frequency of diagnostic change to melanoma (upstaging) and the frequency of local recurrence after MMS for AIMP. A secondary outcome was the frequency of subclinical spread (defined as the requirement for >1 stage of MMS to achieve tumor-free margins). Researchers performed a retrospective, cross-sectional study of 223 AIMP (with 92.4% located on the head, neck, hand, foot, or pretibial leg) treated with MMS with MART-1 immunostaining. They found:

  • Upstaging to unequivocal melanoma in situ (MIS) or invasive melanoma was identified in 18.8% (42/223) of all AIMP.
  • The local recurrence rate was 0% (0/223) with a mean follow-up time of 2.7 years (998 days).
  • Subclinical spread was present in 23.8% (53/223) of AIMP.
Citation:

Etzkorn JR, Jew OS, Shin TM, Sobanko JF, Neal DE, Miller CJ. Mohs micrographic surgery (MMS) with MART-1 immunostaining for atypical intraepidermal melanocytic proliferation (AIMP). [Published online ahead of print July 9, 2018]. J Am Acad Dermatol. doi:10.1016/j.jaad.2018.06.058.

This Week's Must Reads

Patient Motivations for Seeking Cosmetic Procedures, JAMA Dermatology; ePub 2018 Aug 15; Maisel, et al

Pathology Methods for Melanocytic Lesions Compared, JAMA Dermatology; ePub 2018 Aug 15; Onega, et al

Renal Transplant Rejection Linked with Risk of cSCC, Clin Exp Dermatol; ePub 2018 Jun 27; Puza, et al

Microneedling Treatment Improves Skin Aging, J Clin Aesthet Dermatol; 2018 Aug 1; Ablon

Rejuvenation Procedure Proves Safe and Effective , Lasers Surg Med; ePub 2018 Aug 8; Knight, Kautz

Must Reads in Melanoma

Sunless Tanning and Risky Cancer-related Behaviors, JAMA Dermatology; ePub 2018 Jul 25; Dodds, Arron, et al

Incidence of Melanoma, Survival Investigated, J Invest Dermatol; ePub 2018 Jul 19; Nosrati, et al

AAD’s Skin Cancer Screening Program Assessed, J Am Acad Dermatol; ePub 2018 Jul 26; Okhovat, et al

Women Have Greater Lifetime Exposure to arUVR, J Am Acad Dermatol; ePub 2018 Jul 15; Li, Kulkarni, et al

Assessing the Public’s Knowledge of Sunscreen Use, J Cosmet Dermatol; ePub 2018 Jul 16; Cao, Brehm, et al